Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma - Poll - MDSpire

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

UCI Health medical oncologist Poorva Vaidya, MD is currently offering a new clinical trial sponsored by the UC Irvine Anti-Cancer Challenge, and lead by Warren Chow, MD, aimed at tackling a persistent challenge in melanoma care if patients fail first-line immunotherapy.

  • June 24, 2026

Share

Original Source(s)

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

  • June 24, 2026

Related Content

Alectinib combined with 5-aminolevulinic acid-based photodynamic therapy promotes apoptosis in endometrial cancer cells by targeting ferrochelatase

Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer

Therapeutic inhibition of RAS in non-small cell lung cancer